T ranscatheter mitral valve-in-valve or valve-in-ring implantation is feasible using prostheses designed for the aortic valve. 1,2 Implantation in the native mitral annulus presents distinct challenges: available aortic prostheses are too small, valve fixation is difficult because the annulus is elastic, and the subvalvular apparatus, which plays an important role in left ventricular function, should not be disrupted. At least 4 dedicated devices have undergone early human testing. [3] [4] [5] These are bulky and require large caliber access ports (up to 32F), mostly transapical.
Transthoracic Left Atrial Access and Closure transjugular transseptal, 16, 17 and transfemoral transseptal. 18 However, a minithoracotomy still confers surgical morbidity. Transseptal delivery of large mitral implants has been demonstrated, but achieving coaxiality with the mitral valve can remain challenging. A straight shot to the mitral valve that permits large sheath access but does not violate the LV myocardium would be desirable and could reduce the engineering constraints of miniaturization, reduce procedural complexity, and improve patient outcomes.
Percutaneous left atrial (LA) access was first performed in the 1950s using long needles through the posterior chest wall to sample pressure. 19, 20 At first glance, delivering large sheaths via this approach seems challenging because of interposed lung, but there is extensive surgical evidence that temporarily collapsing a lung to perform an intrathoracic intervention is safe. 21 In fact, diagnostic thoracoscopy with iatrogenic lung deflation is commonly performed in awake patients and confers extremely low morbidity and mortality. 22 Percutaneous transthoracic cardiac catheterization has also been performed in children with no alternative access, through the anterior chest into the pulmonary venous atrium and through the lower back into the inferior vena cava. 23, 24 We hypothesized that with imaging guidance and percutaneous techniques, it is possible to access the LA directly through the posterior chest wall by first displacing a lung with gas, then delivering a large sheath, and finally closing the LA port using off-the-shelf nitinol cardiac occluder devices. Compared with percutaneous transapical LV closure, we think that closing a port in the lower pressure LA may be preferable. Because of anatomic differences between large mammals and human, we tested this hypothesis in 2 different large animal models (porcine and ovine) and then explored feasibility of clinical translation with human cardiac computed tomographic (CT) analysis and human cadaver testing. We also explored different image guidance modalities, MRI and x-ray fluoroscopy, to simplify translation into patients.
Methods

Animal Experiments
The institutional animal care and use committee approved all procedures, which were performed according to contemporary National Institutes of Health guidelines. Animals were anesthetized with ketamine (25 mg/kg), midazolam (15 mg/kg), and glycopyrrolate (0.01 mg/kg) and maintained on sevoflurane (1%-4%) and mechanical ventilation. Femoral arterial and venous access was obtained with ultrasound guidance with animals supine.
The technique was developed in nonsurvival experiments on 10 naïve Yorkshire swine, not further described here. Subsequently, survival experiments were performed in 10 naïve Yorkshire swine with median bodyweight 51 kg (47-54 kg) and 2 naïve Dorset sheep (28 and 36 kg), all of which were survived for at least 7 days before euthanasia and necropsy.
Imaging
Experiments were performed first using MRI at 1.5T (Aera, Siemens) and later using biplane x-ray fluoroscopy enhanced by C-arm CT (Artis Zee and DynaCT, Siemens). Experiments are summarized in Figure 1 . For MRI, trajectories were planned on isotropic 3-dimensional images, and the procedure was performed using custom MRIantenna needles 25 and real-time MRI at frame rates ≤15 fps. MRI parameters and devices are provided in the Data Supplement.
Pericardial Autotransfusion Catheter Placement
An 8.3F multi-sidehole subxiphoid pericardial drain was placed after transatrial microcatheter CO 2 insufflation as described 26 and connected to the femoral vein to facilitate immediate autotransfusion for blood salvage. Unfractionated heparin (500-1000 IU) was infused into the pericardial space to prevent in situ thrombus.
Pleural CO 2 Insufflation to Displace Lung
A needle was advanced through the left lateral chest wall during small puffs of iodinated or gadolinium contrast (for x-ray or MRI visualization, respectively) until the pleural space was entered ( Figure 2 ). This was exchanged for an 8.3F multi-sidehole pleural drain positioned in a dependent position to aspirate fluid but not CO 2 . As with the pericardium, 500 to 1000 IU of unfractionated heparin was infused into the pleural space to prevent in situ thrombus formation and facilitate autotransfusion. The pleural space was insufflated with CO 2 titrated to displace lung sufficiently to allow a clear trajectory to the
WHAT IS KNOWN
• Transcatheter mitral valve replacement requires a large caliber sheath and coaxiality between the delivery system and the mitral valve.
• Transapical access may not be an option in all patients, so alternative approaches are needed.
WHAT THE STUDY ADDS
• Fully percutaneous transthoracic left atrial access and closure is feasible in large animal models and affords superb coaxiality with the mitral valve.
• The procedure can be guided using x-ray fluoroscopy or real-time MRI.
• Cardiac computed tomographic analysis and human cadaver feasibility testing indicate that the left atrium can be accessed with a large caliber sheath through the posterior chest wall in humans. 
Transthoracic LA Trajectory Planning and Access
Three-dimensional MRI or x-ray (C-arm CT and biplane fluoroscopy contrast angiograms) of the LA was acquired at baseline and after pleural insufflation. For x-ray guidance, we used a superimposed C-arm CT of LA and LV angiograms (syngo InSpace EP, Siemens). Swine and sheep were positioned respectively on the right side or prone to optimize working angles. A 20-cm needle was used to puncture through the posterior or lateral chest wall, pass through the empty pleural space, and enter the LA posteriorly ( Figures 3 and 4 ). Needle tip position was confirmed by atrial pressure waveform and contrast injection. A stiff nitinol guidewire (Nitrex, Covidien) was introduced through the mitral valve to the LV apex, over which a 18F sheath (outer diameter, 7 mm; Large Check-Flo, Cook) and a customshortened dilator were advanced into the LA without predilatation. Sheath position and relation to the mitral valve were confirmed using MRI or biplane contrast angiography.
LA Closure
The LA port was closed with an off-the-shelf 5-or 6-mm nitinol atrial septal occluder (St Jude Medical, MN; Lepu Medical, Beijing, China). The distal disc was deployed within the LA, and the sheath and delivery catheter were withdrawn in tandem until the disc was in apposition with the LA wall. The proximal disc was deployed outside the heart within the pleural space, and the device was released.
Human Cadaver Study and Human CT Analysis
To explore feasibility for humans, we tested percutaneous transthoracic LA access and closure in 3 human cadavers (1 under MR and 2 under x-ray guidance). After femoral access, the cadavers were rolled prone and all procedural steps were identical to those previously described for animal procedures, using a larger sheath (Ascendra, Edwards Lifesciences, 26F/30F inner/outer diameter).
We also examined 10 random cardiac CT angiograms having full chest wall coverage among patients with mitral valve disease, dilated LA, or previous sternotomy in the National Heart, Lung, and Blood Institute anonymized and delinked database. This does not constitute human subjects research under US 45CFR §46.102(f). Each CT was examined for potential trajectories to the LA.
Statistical Analysis
Hemodynamic data are reported in the Table as median with first and third quartiles (Q1-Q3). Each hemodynamic parameter was analyzed in a linear mixed model with autoregressive-moving-average (1,1) correlation structure assumed within each animal. The model fit mean levels of each parameter at each of the 4 postbaseline follow-up measurements with baseline as the reference. Because there were 4 follow-up measures for each of 3 hemodynamic parameters, we used a Bonferroni correction factor of 12 to account for multiple comparisons. A multiplicity corrected P value ≤0.05 was considered statistically significant.
Results
Pericardial Access for Autotransfusion Catheter Placement
Transatrial pericardial access with a 2.8F microcatheter, insufflation of the pericardial space with CO2, placement of a subxiphoid 8.3F drain, and withdrawal of the transatrial microcatheter was uncomplicated in all 12 animals.
Pleural Insufflation
Pleural access and left lung deflation with CO 2 was uncomplicated in all 12 animals. 600 to 900 mL of CO 2 was required to displace the lung sufficiently to establish an unobstructed trajectory to the LA in both species. Pleural pressures remained low (8-10 mm Hg) and, despite lung displacement, ventilation was well tolerated with no increase in expired CO 2 or evidence of hemodynamic compromise (Table) . Reductions in mean arterial pressure and heart rate were observed after pleural insufflation, which were likely caused by an increase in the inhaled anesthetic agent concentration required to allow for the reduction in ventilator tidal volumes. However, these changes were not statistically significant. 
Trajectory Planning
In swine, pleural insufflation caused the heart to rotate, displacing the long axis of the LV by 7° (6°-14°) compared with baseline. A direct trajectory to the LA, avoiding important anatomic structures was achievable in all animals. Distance from skin to LA was 10 cm (9-11 cm) in swine and 11 cm in both sheep.
Transthoracic LA Access and Closure
The LA was successfully accessed in 10/10 swine, including 8 under MR guidance ( Figure 3 ; Movie I in the Data Supplement) and 2 under x-ray guidance (Figure 4 ; Movie II in the Data Supplement). All succeeded in a single needle pass except in 1, wherein a custom needle that had become dull required a second pass. The stiff nitinol guidewire was positioned in the LV apex, over which the 18F sheath was advanced without predilation. Sheath advancement displaced the LA wall by 25 mm (20-30 mm; under x-ray guidance), but the wall recoiled as soon as the sheath tip entered the LA. No pericardial or pleural effusions developed during LA puncture or while the large sheath remained in place. Three-dimensional and cine MRI confirmed that the sheath trajectory was offset relative to the long axis of the LV by an angle α of ≤30° ( Figure 3 ). The LA port was successfully closed with a single nitinol cardiac occluder device in all animals. During sheath withdrawal and LA port closure, accumulated blood was autotransfused intermittently using the prepositioned pericardial and pleural drains. Median pericardial and pleural autotransfusion volumes were 55 mL (40-73 mL) and 10 mL (10-75 mL), respectively. Animals were stable hemodynamically throughout, and no arrhythmias were observed (Table) .
The LA was successfully accessed with a single pass and closed under MRI guidance in 2/2 sheep. One animal had minimal pericardial effusion (50 mL). The second required higher than expected intraprocedural autotransfusion (300 mL) without any hemodynamic compromise. Pleural effusion was negligible in both animals (10 and 20 mL).
There was no procedural mortality and all animals recovered uneventfully. At the end of the procedure, the pericardial and pleural spaces were aspirated to dryness, any remaining pleural CO 2 was aspirated, and the drains were withdrawn. . D, Filled with gadolinium contrast, the sheath trajectory to the LA is apparent. There is a passive marker at the tip of the sheath (arrow). The angle α represents the offset between the sheath trajectory and the long axis of the LV (dotted red line). E, A nitinol cardiac occluder device is loaded onto an active delivery cable, which incorporates MRI electronics for visualization. The distal disk is deployed within the LA and pulled back against the posterior wall (arrow). The proximal disk is deployed outside the heart. F, Seven days later, the nitinol cardiac occluder device remains in the intended position with no pericardial effusion. Transthoracic Left Atrial Access and Closure
Follow-Up
No complications were observed during the follow-up period of 7.5 days (7-8.5 days). Follow-up MRI confirmed stable position of the LA occluder device in all animals. Twelve of 12 animals had no pleural effusion. Eleven of 12 animals had no detectable or trace pericardial effusion 0 mL (0-6 mL). One pig, in which the LA was punctured twice, had a large but hemodynamically insignificant pericardial effusion (660 mL) at 7 days follow-up. No other complications were observed in any animal and all skin incisions healed well. On necropsy, the nitinol cardiac occluder device was well seated and fibrosed to the LA wall in all animals (data not shown).
Human CT Analysis
Cardiac CT angiograms from 10 patients (age 68years [59-73 years], 8/10 male) with full chest wall coverage were examined. A direct trajectory to the LA through the right posterior chest wall was achievable in all ( Figure 5 ; Movie III in the Data Supplement). The right lung would need to be displaced by pleural insufflation, but the trajectory avoided important structures, including descending aorta and esophagus. The mean angle α between the achievable trajectory and the true long axis of the LV was 5° (4°-7°). Mean intercostal distance at the point of entry through the chest wall was 12 mm (11-15 mm).
We also tested whether there was a trajectory to the mitral valve from a right minithoracotomy incision, entering the right atrium, and passing through the interatrial septum. In all 10 patients this was achievable, but the offset angle between the trajectory and the true long axis of the LV was 56° (51°-58°).
Human Cadaver Study
In the prone position, right pleural insufflation and deflation of the right lung were straightforward whether under MR or x-ray guidance. This exposed a direct trajectory to the posterior wall of the LA avoiding other important structures, such as aorta and esophagus, in all 3 cadavers. The LA was successfully entered and a large 26F sheath was delivered. Pleural insufflation did not cause the heart to shift orientation within the thorax. As a result, the sheath trajectory remained well aligned with the long axis of the LV. The LA port was closed using a nitinol cardiac occluder device, and the right lung was reinflated by aspirating the pleural CO 2 (Figure 6 ; Movie IV in the Data Supplement).
Discussion
We describe a novel percutaneous technique to access the left heart to deliver interventional devices. The technique combines several innovations: (1) fully percutaneous transthoracic LA access with a needle followed by a large sheath;
(2) pericardial autotransfusion catheter placement; (3) pleural The 2 sheep were smaller animals with lower baseline blood pressure so were excluded from the analysis of hemodynamics. No differences retained statistical significance after correction for multiplicity. Data are presented as median (Q1-Q3). HR indicates heart rate; and MAP, mean arterial blood pressure. 
Pleural Insufflation to Create Unobstructed Trajectory to LA
Thoracoscopy to inspect the pleura, perform biopsy, or deliver therapy is an established technique usually performed under moderate sedation. 27 More advanced procedures, for example, lobectomy or management of spontaneous pneumothorax, are typically performed under general anesthesia with duallumen endotracheal tube to facilitate single lung ventilation and have excellent perioperative outcomes. 21, 28, 29 However, there is evidence that such interventions can be well tolerated in conscious nonintubated patients 30 even for long procedures and in older sicker patients. 31 Based on this extensive clinical experience, there is reason to expect that single lung deflation for the purpose of transthoracic LA access may be tolerated in patients.
Choice of Imaging Modality to Guide LA Access
The superior soft tissue visualization and multiplanar viewing capabilities of MRI are appealing to guide minimally invasive interventions, particularly interventions that violate vascular boundaries, in which every anatomic structure traversed must be visualized. MRI provides this capability. In this study, we demonstrated that LA access and closure could be safely performed using real-time MRI guidance. MRI also permitted easy access to the pleural space and titration of pleural insufflation to displace lung. Crucially, MRI afforded continuous monitoring for development of pericardial and pleural effusions during LA puncture and closure. Any accumulation of blood in the pericardial or pleural space was immediately identified and autotransfused.
Nonetheless, we explored whether the procedure could be performed using x-ray fluoroscopy. A transseptal pigtail catheter was positioned in the LA. Biplane contrast angiography and intrapericardial iodinated contrast delineated LA anatomy adequately. This enabled a trajectory to the LA to be planned in orthogonal x-ray projections. It was difficult to definitely establish adequate lung displacement using fluoroscopy only, but C-arm CT provided clear visualization of lung tissue and assurance of satisfactory lung displacement. In humans, where the preferred LA puncture site should be posterior and midway between left and right pulmonary vein ostia, dual transseptal guidewires in left and right pulmonary veins could offer a precise fluoroscopic target for LA puncture. Echocardiography could provide a substitute for real-time MRI to monitor for pericardial blood accumulation and guide autotransfusion.
We also explored using color overlays of the LA and LV, segmented from contrast-enhanced C-arm CT using software designed to guide electrophysiology procedures. The fusion images enhanced our ability to predict trajectories and determine optimal LA puncture location (Figure 4 ). In addition, the overlays aided in selecting optimal x-ray projection angles and may have reduced overall iodinated contrast usage.
Closure of LA Port
There is clinical precedent for the use of off-label nitinol cardiac occluder devices to seal large holes in vascular structures, including the LV apex or abdominal aorta. 13, 32 Even in the high-pressure LV, hemostasis was rapidly achieved with reversal of anticoagulation. Hemostasis should be easier to achieve in the LA because the pressure is much lower than in the LV or systemic arteries, even in patients with mitral valve disease. In some animals, blood did accumulate in the pericardial or pleural space, but was easily managed by aspiration and autotransfusion, akin to standard surgical blood salvage technique. After aspirating to dryness, all drains were removed post procedure for animal comfort-although in humans they would be left in overnight. Only 1 large but hemodynamically insignificant pericardial effusion was observed at follow-up, in the 1 animal in which 2 LA punctures were made because a custom needle 
Feasibility of Clinical Translation
We tested LA access and closure in 2 large animal models to determine whether the approach was feasible in different anatomies. The trajectories for unobstructed access to the LA were different in the 2 species but easily achievable by deflating the left lung. Importantly, all animals were hemodynamically stable with a large sheath in the LA. This approach could circumvent many of the risks associated with transapical access in patients with advanced mitral valve disease, in particular, acute hemodynamic instability and late LV pseudoaneurysm, ventricular arrhythmias, and decrement in LV function.
Human cardiac CT angiogram analysis confirmed that a theoretical trajectory exists in humans. In swine, pleural insufflation rotated the heart in the thorax, which resulted in an offset between the long axis of the heart and the achieved trajectory ( Figure 3 ). Because the orientation of the heart in the human mediastinum is different, the trajectory is different from that in swine or sheep. In humans, the right lung would be deflated to puncture the LA posteriorly between the pulmonary veins ( Figure 5 ). In this configuration, right lung deflation would deflect the right pulmonary veins away from the needle trajectory, exposing the posterior wall of the LA. This trajectory avoids other important structures, such as the aorta and esophagus. The mean intercostal distance at the point of entry through the chest wall was sufficient to accommodate a sheath 32F or larger.
To demonstrate that this trajectory was feasible, we accessed the LA in human cadavers and delivered a large sheath under either MRI or x-ray guidance ( Figure 6 ). Pleural insufflation did not shift the orientation of the heart within the thorax in cadavers. We then closed the LA port with a nitinol cardiac occluder device and re-expanded the right lung.
Limitations
There are anatomic differences between humans and swine. For example, the descending aorta and esophagus vary in position within the thorax. Procedural tomography (such as C-arm CT and real-time MRI) is therefore recommended for trajectory planning. Pulmonary disease or chronic heart failure could increase the risk of single lung ventilation. Clotting disorders could increase bleeding. Off-label nitinol cardiac occluder devices may not assure hemostasis. Prior cardiothoracic surgery may cause pleural adhesions, which could impede lung displacement. Because our technique involves 2 points of fixation (chest wall and LA wall), sheath maneuverability is constrained. However, because excellent alignment with the LV long axis can be achieved by careful trajectory planning, we do not anticipate that excessive sheath manipulation would be required to achieve coaxial alignment to perform a mitral valve intervention.
Technical Considerations for Clinical Translation
To perform this procedure in patients under x-ray fluoroscopy guidance, we envision the following provisions: (1) The procedure would be performed under general anesthesia with a dual lumen endotracheal tube and bronchial blockers to facilitate intentional right lung collapse and single lung ventilation. (2) The patient would be positioned initially supine for standard percutaneous access and then rolled prone for transthoracic atrial access. (3) A temperature or transesophageal echocardiography probe would be used to identify the esophagus. (4) A pericardial drain may not be required in patients with prior sternotomy and pericardial adhesions. (5) Respiration would be suspended during LA puncture. (6) The guidewire would be advanced through the mitral valve into the LV over a balloon catheter to prevent chordal entrapment. (7) Anticoagulation would be reversed with protamine immediately before cardiac occluder device deployment. (8) A coaxial buddy wire would be used during LA port closure to allow LA access to be reestablished rapidly in case of inadvertent pull through of the nitinol cardiac occluder device. (9) Pleural and pericardial drains would be left in place for a short period after the procedure to drain any effusions.
Conclusions
Fully percutaneous transthoracic LA access is feasible to deliver large interventional devices to the mitral valve without violating the LV myocardium. The procedure can be guided by a variety of imaging modalities, although in our experience MRI guidance offers the greatest visualization of anatomic structures with the ability to monitor and address complications in real-time, for example, pericardial effusion. Clinical translation seems feasible based on human cardiac CT analysis and human cadaver testing. This technique could provide a direct and coaxial access route for transcatheter mitral valve interventions in the future.
